ChemicalBook >> CAS DataBase List >>HDAC inhibitor
HDAC inhibitor
- CAS No.
- 660847-06-3
- Chemical Name:
- HDAC inhibitor
- Synonyms
- HDAC-IN-21;HDAC inhibitor;Ac-Leu-Gly-Lys (Ac)-AMC;N-Acetyl-L-leucylglycyl-N6-acetyl-N-(4-Methyl-2-;N-Acetyl-L-leucylglycyl-N6-acetyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-L-lysinamide;L-Lysinamide, N-acetyl-L-leucylglycyl-N6-acetyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-;(S)-6-Acetamido-2-(2-((S)-2-acetamido-4-methylpentanamido)acetamido)-N-(4-methyl-2-oxo-2H-chro;(S)-6-acetamido-2-(2-((S)-2-acetamido-4-methylpentanamido)acetamido)-N-(4-methyl-2-oxo-2H-chromen-7-yl)hexanamide;(2S)-6-Acetamido-2-[[2-[[(2S)-2-acetamido-4-methylpentanoyl]amino]acetyl]amino]-N-(4-methyl-2-oxochromen-7-yl)hexanamide;HDAC inhibitor/(S)-6-acetamido-2-(2-((S)-2-acetamido-4-methylpentanamido)acetamido)-N-(4-methyl-2-oxo-2H-chromen-7-yl)hexanamide
- CBNumber:
- CB72521087
- Molecular Formula:
- C28H39N5O7
- Molecular Weight:
- 557.64
- MDL Number:
- MFCD22380596
- MOL File:
- 660847-06-3.mol
Last updated:2023-05-26 08:28:50
Boiling point | 980.1±65.0 °C(Predicted) |
---|---|
Density | 1.219 |
storage temp. | Sealed in dry,Room Temperature |
pka | 12.52±0.20(Predicted) |
NCI Dictionary of Cancer Terms | HDAC inhibitor |
SAFETY
Risk and Safety Statements
Symbol(GHS) | GHS07 |
---|---|
Signal word | Warning |
Hazard statements | H302-H315-H319-H335 |
Precautionary statements | P261-P305+P351+P338 |
HDAC inhibitor price
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
TRC | A630580 | (2S)-6-Acetamido-2-[[2-[[(2S)-2-acetamido-4-methylpentanoyl]amino]acetyl]amino]-N-(4-methyl-2-oxochromen-7-yl)hexanamide | 660847-06-3 | 2.5mg | $220 | 2021-12-16 | Buy |
AK Scientific | Y0336 | N-Acetyl-L-leucylglycyl-N6-acetyl-N-(4-methyl-2-oxo-2H-chromen-7-yl)-L-lysinamide | 660847-06-3 | 50mg | $523 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | INB0001398 | (S)-6-ACETAMIDO-2-(2-((S)-2-ACETAMIDO-4-METHYLPENTANAMIDO)ACETAMIDO)-N-(4-METHYL-2-OXO-2H-CHROMEN-7-YL)HEXANAMIDE 95.00% | 660847-06-3 | 5MG | $614.21 | 2021-12-16 | Buy |
DC Chemicals | DC5085 | HDACinhibitor >98% | 660847-06-3 | 250mg | $800 | 2021-12-16 | Buy |
Ambeed | A197016 | (S)-6-Acetamido-2-(2-((S)-2-acetamido-4-methylpentanamido)acetamido)-N-(4-methyl-2-oxo-2H-chromen-7-yl)hexanamide 97% | 660847-06-3 | 5mg | $55 | 2021-12-16 | Buy |
Synthesis of HDAC inhibitor from L-Lysinamide, N-acetyl-L-leucylglycyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-, 2,2,2-trifluoroacetate (1:1) and Acetic anhydride
HDAC inhibitor Preparation Products And Raw materials
Raw materials
Preparation Products
HDAC inhibitor Suppliers
Global( 32)Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
Guangzhou CATO Research Chemicals Inc. | +86-020-81960175-617 +8615602392859 | Intermediate@cato-chem.com | China | 8047 | 58 |
Amadis Chemical Company Limited | 571-89925085 | sales@amadischem.com | China | 131957 | 58 |
ChemCell Biomedicine Co.,Ltd. | 020-13556033878 2965585218 13556033878 | chemcell@hotmail.com | China | 369 | 52 |
Xunteng International Trading Co.,Limited | China Hong Kong | 878 | 55 | ||
Shanghai Send Pharmaceutical Technology Co., Ltd. | 021-58088081 Q3382968513 | hailey@shsendpharm.com | China | 3129 | 55 |
Shanghai Brain Biotechnology Co., Ltd. | 13564638271 | sales@brain-biot.com | China | 2987 | 55 |
Shanghai YuanYe Biotechnology Co., Ltd. | 021-61312847; 18021002903 | 3008007409@qq.com | China | 27313 | 60 |
ShangHai Biochempartner Co.,Ltd | 177-54423994 17754423994 | 2853530910@QQ.com | China | 8012 | 62 |
Amatek Scientific Co. Ltd. | 0512-56316828 | info@amateksci.com | China | 28806 | 58 |
Aikon International Limited | 025-58851090 13611564524 | lwan@aikonchem.com | China | 15951 | 58 |
(S)-6-acetamido-2-(2-((S)-2-acetamido-4-methylpentanamido)acetamido)-N-(4-methyl-2-oxo-2H-chromen-7-yl)hexanamide
HDAC inhibitor
(S)-2-(2-((S)-2-acetamido-4-methylpentanamido)acetamido)-N-(4-methyl-2-oxo-2H-chromen-7-yl)-6-(2,2,2-trifluoroacetamido)hexanamide
N-Acetyl-L-leucylglycyl-N6-acetyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-L-lysinamide
N-Acetyl-L-leucylglycyl-N6-acetyl-N-(4-Methyl-2-
(S)-6-Acetamido-2-(2-((S)-2-acetamido-4-methylpentanamido)acetamido)-N-(4-methyl-2-oxo-2H-chro
(2S)-6-Acetamido-2-[[2-[[(2S)-2-acetamido-4-methylpentanoyl]amino]acetyl]amino]-N-(4-methyl-2-oxochromen-7-yl)hexanamide
HDAC-IN-21
Ac-Leu-Gly-Lys (Ac)-AMC
L-Lysinamide, N-acetyl-L-leucylglycyl-N6-acetyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-
HDAC inhibitor/(S)-6-acetamido-2-(2-((S)-2-acetamido-4-methylpentanamido)acetamido)-N-(4-methyl-2-oxo-2H-chromen-7-yl)hexanamide
660847-06-3
C28H39N5O7
Inhibition of class IIa HDACs by acetylated lysine-based substrates substrates